Clinical trial
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral…
NCT00196599 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00196599 |
|---|---|
| Title | Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults |
| Official title | Pilot Study on Efficacy and Safety of a Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults. ANRS 091 MONTANA |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | Triangle Pharmaceuticals Industry Gilead Sciences Bristol-Myers Squibb Dupont Applied Biosciences |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Antiretroviral Naive |
| Intervention type | Drug |
| Interventions | emtricitabine, FTC (drug), didanosine, ddI (drug), efavirenz (drug) |
| Enrollment | 39 |
| Start date | Feb 1, 1999 |
| Completion | Sep 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 20, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: